Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

The CATT Research Group·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1102673

Cited by (1,010)

Items 201–300 of 1,010

Serum cytokines as biomarkers for age-related macular degeneration
Khaled Nassar, Salvatore Grisanti, Elshaymaa Elfar, Julia Lüke, Matthias Lüke, Swaantje Grisanti · 2014 · Graefe s Archive for Clinical and Experimental Ophthalmology
Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Benjamin Michael Davis, Milena Pahlitzsch, Li Guo, Shiama Indu Balendra, Parth Arvind Shah, Nivedita Ravindran, Giulia Malaguarnera, Claudia Sisa, Ehtesham Shamsher, Hisham Hamze et al. · 2018 · Scientific Reports
Role of Oxidative Stress in Ocular Diseases: A Balancing Act
Daisy Y. Shu, Suman Chaudhary, Kin‐Sang Cho, Anton Lennikov, William P. Miller, David C. Thorn, Menglu Yang, Tina B. McKay · 2023 · Metabolites
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration
Charles C. Wykoff, David M. Brown, Kimberly Reed, Alyson J. Berliner, Adam T. Gerstenblith, Aurora Breazna, Prema Abraham, Jordana Goren Fein, Karen W Chu, W. Lloyd Clark et al. · 2023 · JAMA Ophthalmology
Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life
Katharina Dröge, Philipp Sebastian Muether, Manuel Marcel Hermann, Albert Caramoy, Ulrike Viebahn, Bernd Kirchhof, Sascha Fauser · 2012 · Graefe s Archive for Clinical and Experimental Ophthalmology
Real-world outcomes of anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration in the United States
Ciulla, Thomas A., Huang, Forbes, Westby, Keith, Williams, David F., Zaveri, Sandi, Patel, Samir C. · 2018 · Ophthalmology Retina
Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration
Usha Chakravarthy, Dafna Goldenberg, Graham Young, Moshe Havilio, Omer Rafaeli, Gidi Benyamini, Anat Loewenstein · 2016 · Ophthalmology
Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
Natalie Jia Ying Yeo, Ebenezer Jia Jun Chan, Christine Cheung · 2019 · Frontiers in Pharmacology
Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset
Monés, Jordi, Singh, Rishi P., Bandello, Francesco, Souied, Eric, Liu, Xin, Gale, Richard · 2020 · Ophthalmologica
Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
Szilárd Kiss, Ying Liu, Joseph G. Brown, Nancy M. Holekamp, Arghavan Almony, Joanna H. Campbell, Jonathan W. Kowalski · 2014 · Clinical ophthalmology
Ultra-Widefield Steering-Based Spectral-Domain Optical Coherence Tomography Imaging of the Retinal Periphery
Netan Choudhry, John Golding, Matthew W. Manry, Rajesh C. Rao · 2016 · Ophthalmology
Intraocular Pharmacokinetics of Ranibizumab in Vitrectomized Versus Nonvitrectomized Eyes
Seong Joon Ahn, Jeeyun Ahn, Sun Young Park, Hyuncheol Kim, Daniel Duck-Jin Hwang, Ji Hyun Park, Ji Yeon Park, Jae‐Yong Chung, Kyu Hyung Park, Se Joon Woo · 2014 · Investigative Ophthalmology & Visual Science
Aptamers in biomedicine: Selection strategies and recent advances
Geanina Ștefan, Oana Hosu, Karolien De Wael, Marı́a Jesús Lobo-Castañón, Cécilia Cristea · 2021 · Electrochimica Acta
Update on depression and age-related macular degeneration
Robin J. Casten, Barry W. Rovner · 2013 · Current Opinion in Ophthalmology
Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration
Sebastian M. Waldstein, Ana-Maria Philip, Roland Leitner, Christian Simader, Georg Langs, Bianca S. Gerendas, Ursula Margarethe Schmidt-Erfurth · 2015 · JAMA Ophthalmology
Risk-Sharing Arrangements That Link Payment For Drugs To Health Outcomes Are Proving Hard To Implement
Peter J. Neumann, James D. Chambers, Françoise L. Simon, Lisa M. Meckley · 2011 · Health Affairs
Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases
Melissa K. Jones, Bin Lü, Sergey Girman, Shaomei Wang · 2017 · Progress in Retinal and Eye Research
Bacterial Dispersal Associated With Speech in the Setting of Intravitreous Injections
Joanne C. Wen · 2011 · Archives of Ophthalmology
Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
Ebenezer Daniel, James Shaffer, Gui‐Shuang Ying, Juan E. Grunwald, Daniel Francis Martin, Glenn J. Jaffe, Maureen G. Maguire · 2015 · Ophthalmology
Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials
Qiang Zhou, Ebenezer Daniel, Maureen G. Maguire, Juan E. Grunwald, E. Revell Martin, Daniel Francis Martin, Gui‐Shuang Ying · 2016 · Ophthalmology
Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials
Gui‐Shuang Ying, Benjamin J. Kim, Maureen G. Maguire, Jiayan Huang, Ebenezer Daniel, Glenn J. Jaffe, Juan E. Grunwald, Kevin J. Blinder, Christina J. Flaxel, Firas M. Rahhal et al. · 2014 · JAMA Ophthalmology
The leukotriene receptors as therapeutic targets of inflammatory diseases
F Sasaki, Takehiko Yokomizo · 2019 · International Immunology
RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Frank Gerhard Holz, Marta S. Figueroa, Francesco Maria Bandello, Yit Chiun Yang, Masahito Ohji, Hong Dai, Halina Wykrota, Sanjay Sharma, Cornelia Dunger‐Baldauf, Sue Lacey et al. · 2019 · Retina
Profile of conbercept in the treatment of neovascular age-related macular degeneration
Xiaodong Sun, Xinmin Lu · 2015 · Drug Design Development and Therapy
Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT)
Gui‐Shuang Ying, Maureen G. Maguire, Ebenezer Daniel, Frederick L. Ferris, Glenn J. Jaffe, Juan E. Grunwald, Cynthia Ann Toth, Jiayan Huang, Daniel Martín · 2015 · Ophthalmology
NLRP3 Inflammasome and Pathobiology in AMD
Lucia Celkova, Sarah Doyle, Matthew Campbell · 2015 · Journal of Clinical Medicine
Visual Impairment and Blindness Due to Macular Diseases Globally: A Systematic Review and Meta-Analysis
Jost Bruno Jonas, Rupert Bourne, Richard Aubrey White, Seth R Flaxman, Jill Elizabeth Keeffe, Janet L Leasher, Kovin Shunmugam Naidoo, Konrad Pesudovs, Holly Price, Tien Yin Wong et al. · 2014 · American Journal of Ophthalmology
NLRP3 Inflammasome Blockade Inhibits VEGF-A-Induced Age-Related Macular Degeneration
Alexander G. Marneros · 2013 · Cell Reports
Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration
Dženita Smailhodzic, Philipp Sebastian Muether, John Li Chen, Angela Kwestro, Alice Yang Zhang, Amer Omar, Johannes P. H. van de Ven, JAN E. E. KEUNEN, Bernd Kirchhof, Carel B. Hoyng et al. · 2012 · Ophthalmology
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
Mark T. Bolinger, David A. Antonetti · 2016 · International Journal of Molecular Sciences
Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti–Vascular Endothelial Growth Factor Injections
Anthony Obeid, Xinxiao Gao, Ferhina S. Ali, Christopher M. Aderman, Abtin Shahlaee, Murtaza K. Adam, Sundeep K. Kasi, Leslie Hyman, Allen C. Ho, Jason Hsu · 2018 · JAMA Ophthalmology
Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study
Michèle Augsburger, Gian‐Marco Sarra, Pascal D. Imesch · 2019 · Graefe s Archive for Clinical and Experimental Ophthalmology
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
David Callanan, Anat Loewenstein, Sunil S. Patel, Pascale Massin, Borja Corcóstegui, Xiaoyan Li, Jenny Jiao, Yehia Hashad, Scott M. Whitcup · 2016 · Graefe s Archive for Clinical and Experimental Ophthalmology
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme
Frank Gerhard Holz, Francesco Maria Bandello, Mark C. Gillies, Paul L.R. Mitchell, Aaron R Osborne, Tom Sheidow, Eric H. Souied, Marta S. Figueroa · 2013 · British Journal of Ophthalmology
First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration
James Stephen Talks, Andrew John Lotery, Faruque D. Ghanchi, Sobha Sivaprasad, Robert L. Johnston, Nishal Patel, Martin McKibbin, Clare Bailey, Sajjad Mahmood, Aires Lobo et al. · 2015 · Ophthalmology
Therapies for Macular Edema Associated with Central Retinal Vein Occlusion
Steven Yeh, Stephen Jae Kim, Allen C. Ho, Scott D. Schoenberger, Sophie J. Bakri, Justis P. Ehlers, Jennifer E. Thorne · 2015 · Ophthalmology
A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1
Raja Narayanan, Bhavik Uttam Panchal, Taraprasad Das, Jay Kumar Chhablani, Subhadra Jalali, M. Hasnat Ali · 2015 · British Journal of Ophthalmology
Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients
Ravi Parikh, Joseph S. Ross, Lindsey R. Sangaralingham, Ron Afshari Adelman, Nilay D. Shah, Andrew J. Barkmeier · 2016 · Ophthalmology
A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)
Usha Chakravarthy, Simon Peter Harding, Chris A. Rogers, Susan M. Downes, Andrew John Lotery, Helen Dakin, Lucy A. Culliford, Lauren J Scott, Rachel L Nash, Jodi Taylor et al. · 2015 · Health Technology Assessment
Gene therapy for visual loss: Opportunities and concerns
Jia Hui Lee, Jiang-Hui Wang, Jinying Chen, Fan Li, Thomas L. Edwards, Alex William Hewitt, Guei‐Sheung Liu · 2018 · Progress in Retinal and Eye Research
Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma
Ibrahim H. Eissa, M.K. Ibrahim, Ahmed M. Metwaly, Amany Belal, Ahmed B. M. Mehany, Alsayed A. Abdelhady, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly, Hazem A. Mahdy · 2020 · Bioorganic Chemistry
RPE cell senescence: A key contributor to age-related macular degeneration
Michael R. Kozlowski · 2012 · Medical Hypotheses
Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF
Michael W. Stewart · 2014 · Expert Review of Clinical Pharmacology
Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Diabetic Macular Edema
Allen C. Ho, Ingrid Ursula Scott, Stephen Jae Kim, Gary C. Brown, Melissa M. Brown, Michael S. Ip, Franco Maria Recchia · 2012 · Ophthalmology
Protective effect of autophagy on human retinal pigment epithelial cells against lipofuscin fluorophore A2E: implications for age-related macular degeneration
J Zhang, Yihan Bai, Lan Ji Huang, Yun Qi, Qingbi Zhang, Simin Li, Yalin Wu, Xiting Li · 2015 · Cell Death and Disease
Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study
Daniel Shu Wei Ting, Wei Yan Ng, Si Rui Ng, Shu Pei Tan, Ian Y. S. Yeo, Ranjana Mathur, Choi Mun Chan, Anna C. S. Tan, Gavin Siew Wei Tan, Tien Yin Wong et al. · 2015 · American Journal of Ophthalmology
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study
Jennifer Arnold, Caroline M. Markey, Nicol Kurstjens, Robyn H. Guymer · 2016 · BMC Ophthalmology
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis
Martin Schmid, Lucas M. Bachmann, Livia Faes, Alfons G.H. Kessels, Oliver M. Job, Michael A. Thiel · 2014 · British Journal of Ophthalmology
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY
Matthew P. Simunovic, David Maberley · 2015 · Retina
Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration
Misa Suzuki, Norihiro Nagai, Kanako Izumi‐Nagai, Hajime Shinoda, Takashi Koto, Atsuro Uchida, Hiroshi Mochimaru, Kenya Yuki, Mariko Sasaki, Kazuo Tsubota et al. · 2014 · British Journal of Ophthalmology
TWO YEAR OUTCOMES OF “TREAT AND EXTEND” INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Daniel Barthelmes, Vuong Nguyen, Vincent Daïen, Anna E. Campain, Richard Walton, Robyn H. Guymer, Nigel Morlet, Alex P. Hunyor, Rohan W. Essex, Jennifer Arnold et al. · 2017 · Retina
Systematic review: non-adherence and non-persistence in intravitreal treatment
Christoph Ehlken, Focke Ziemssen, Nicole Eter, Ines M Lanzl, Hakan Kaymak, Albrecht Peter Lommatzsch, Alexander Karl-Georg Schuster · 2020 · Graefe s Archive for Clinical and Experimental Ophthalmology
Surgery for cataracts in people with age-related macular degeneration
Heather Casparis, Kristina B. Lindsley, Irene C Kuo, Shameema Sikder, Neil M Bressler · 2017 · Cochrane Database of Systematic Reviews
Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration
Nurit Mathalone, Anat Arodi-Golan, Shaul Sar, Yulia Wolfson, Mordechai Shalem, Idit Lavi, Orna Geyer · 2012 · Graefe s Archive for Clinical and Experimental Ophthalmology
Four-Year Treatment Results of Neovascular Age-Related Macular Degeneration With Ranibizumab and Causes for Discontinuation of Treatment
Mads Krüger Falk, Henrik Kemp, Torben Lykke Sørensen · 2012 · American Journal of Ophthalmology
Cell–Matrix Interactions in the Eye: From Cornea to Choroid
Andrew E. Pouw, Mark A. Greiner, Razek Georges Coussa, Chunhua Jiao, Ian C. Han, Jessica M. Skeie, John H. Fingert, Robert F. Mullins, Elliott H. Sohn · 2021 · Cells
Incidence of Choroidal Neovascularization in the Fellow Eye in the Comparison of Age-related Macular Degeneration Treatments Trials
Maguire, Maureen G., Daniel, Ebenezer, Shah, Ankoor R., Grunwald, Juan E., Hagstrom, Stephanie A., Avery, Robert L., Huang, Jiayan, Martin, Revell W., Roth, Daniel B., Castellarin, Alessandro A. et al. · 2013 · Ophthalmology
Retinal specialist versus artificial intelligence detection of retinal fluid from OCT
Keenan, Tiarnan D.L., Clemons, Traci E., Domalpally, Amitha, Elman, Michael J., Havilio, Moshe, Agrón, Elvira, Benyamini, Gidi, Chew, Emily Y. · 2021 · Ophthalmology
SIERRA-AMD: a retrospective, real-world evidence study of patients with neovascular age-related macular degeneration in the United States
Khanani, Arshad M., Skelly, Adrian, Bezlyak, Vladimir, Griner, Ray, Torres, Laura Rodriguez, Sagkriotis, Alexandros · 2020 · Ophthalmology Retina
Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes
Magdalena Edington, Julie Connolly, Victor N. Chong · 2017 · Expert Opinion on Drug Metabolism & Toxicology
AI-based monitoring of retinal fluid in disease activity and under therapy
Ursula Margarethe Schmidt-Erfurth, Gregor Sebastian Reiter, Sophie Riedl, Philipp Seeböck, Wolf‐Dieter Vogl, Barbara A. Blodi, Amitha Domalpally, Amani A. Fawzi, Yali Jia, David Sarraf et al. · 2021 · Progress in Retinal and Eye Research
Super-dose Anti-VEGF (SAVE) Trial: 2.0 mg Intravitreal Ranibizumab for Recalcitrant Neovascular Macular Degeneration–Primary End Point
Brown, David M., Chen, Eric, Mariani, Angeline, Major, James C. · 2013 · Ophthalmology
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions
Mark C. Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W. Essex, Stephanie H. Young, David Squirrell, Vuong Nguyen, Daniel Barthelmes · 2019 · American Journal of Ophthalmology
Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study
Chaim M. Bell, S.S. Gill, Susan E. Bronskill, J. Michael Paterson, Marlo Whitehead, Chaim M. Bell · 2012 · BMJ
TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO ANGIOID STREAKS
Martin Gliem, Robert Patrick Finger, Rolf Fimmers, Christian Karl Brinkmann, Frank Gerhard Holz, Peter Charbel Issa · 2013 · Retina
Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular Health
Cynthia J. Owsley, Carrie Huisingh, Mark E. Clark, Gregory R. Jackson, Gerald McGwin · 2015 · Current Eye Research
Oxygen Sensing in Retinal Health and Disease
Lange, Clemens A.K., Bainbridge, James W.B. · 2012 · Ophthalmologica
Current Anti–Vascular Endothelial Growth Factor Dosing Regimens
Julia A. Haller · 2013 · Ophthalmology
Avastin Doesn't Blind People, People Blind People
Serafin Gonzalez, Philip J. Rosenfeld, Michael W. Stewart, Jennifer Brown, Steven P. Murphy · 2012 · American Journal of Ophthalmology
Macular Atrophy in Neovascular Age-Related Macular Degeneration
Mark C. Gillies, Alex P. Hunyor, Jennifer Arnold, Robyn H. Guymer, Sebastián Wolf, Francois L. Pecheur, Marion Ronit Munk, Ian L. McAllister · 2019 · Ophthalmology
Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model
Mehmet Tuzcu, Cemal Orhan, Ömer Ersin Muz, Nurhan Şahin, Vijaya Juturu, Kazım Şahin · 2017 · BMC Ophthalmology
First-line treatment algorithm and guidelines in center-involving diabetic macular edema
Laurent Kodjikian, David Bellocq, Francesco Maria Bandello, Anat Loewenstein, Usha Chakravarthy, Adrian Koh, Albert J. Augustin, Marc D. de Smet, Jay Kumar Chhablani, Adnan Tufail et al. · 2019 · European Journal of Ophthalmology
Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration
Levon Michael Khachigian, Gerald Liew, Kelvin Y. C. Teo, Tien Y. Wong, Paul Mitchell · 2023 · Journal of Translational Medicine
Recent Advances in Age-Related Macular Degeneration Therapies
Marie Fabre, Lou Mateo, Diana Lamaa, Stéphanie Baillif, Gilles Pagès, Luc Demange, Cyril Ronco, Rachid Benhida · 2022 · Molecules
Recent advances in aptamer-based targeted drug delivery systems for cancer therapy
Fei Gao, Jianhui Yin, Yan Chen, Changyong Guo, Honggang Hu, Jiacan Su · 2022 · Frontiers in Bioengineering and Biotechnology
Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
Reem H. ElSheikh, Muhammad Z. Chauhan, Ahmed B. Sallam · 2022 · Biomolecules
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration
Holekamp, Nancy M., Liu, Ying, Yeh, Wei-Shi, Chia, Yifeng, Kiss, Szilárd, Almony, Arghavan, Kowalski, Jonathan W. · 2014 · American Journal of Ophthalmology
Doxycycline Inhibits Polarization of Macrophages to the Proangiogenic M2-type and Subsequent Neovascularization
Lizhi He, Alexander G. Marneros · 2014 · Journal of Biological Chemistry
Clinically relevant deep learning for detection and quantification of geographic atrophy from optical coherence tomography: a model development and external validation study
Gongyu Zhang, Dun Jack Fu, Bart J. Liefers, Livia Faes, Sophie L. Glinton, Siegfried K. Wagner, Robbert Struyven, Nikolas Pontikos, Pearse Andrew Keane, Konstantinos Balaskas · 2021 · The Lancet Digital Health
Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis
Livia Faes, Nicolas S. Bodmer, Lucas M. Bachmann, Michael A. Thiel, Martin Schmid · 2014 · Eye
Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
Christopher Schütze, Manuela Wedl, Bernhard Baumann, Michael Pircher, Christoph K. F. Hitzenberger, Ursula Margarethe Schmidt-Erfurth · 2015 · American Journal of Ophthalmology
Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration
Rehan M. Hussain, Thomas A. Ciulla · 2017 · Expert Opinion on Emerging Drugs
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
Christoph Ehlken, S Jungmann, Daniel Böhringer, Hansjürgen T. Agostini, Bernd Junker, Amelie Pielen · 2014 · Eye
Drug-induced uveitis
Nikolas J. S. London, Sunir J. Garg, Ramana S. Moorthy, Emmett T. Cunningham · 2013 · Journal of Ophthalmic Inflammation and Infection
Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration
Philip J. Rosenfeld · 2016 · Investigative Ophthalmology & Visual Science
The SECURE Study
Rufino Martins da Silva, Ruth Axer‐Siegel, Bora Eldem, Robyn H. Guymer, Bernd Kirchhof, András Papp, András Seres, Margarita Gekkieva, Annette Nieweg, Stefan Pilz · 2012 · Ophthalmology
The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective
Parviz Mammadzada, Pablo Manuel Fernández Corredoira, Helder André · 2019 · Cellular and Molecular Life Sciences
Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors
Kunyong Xu, Eric K. Chin, Steven R. Bennett, David F. Williams, Edwin H. Ryan, Sundeep Dev, Robert A. Mittra, Polly A. Quiram, John B. Davies, David Wilkin Parke et al. · 2018 · Ophthalmology
Evaluation of circulating miRNAs in wet age-related macular degeneration.
Sevda Ertekin, Özlem Yıldırım, Erdem Dinç, Lokman Ayaz, Senay Balcı Fidancı, Lülüfer Tamer · 2014 · PubMed Central
Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
Philipp Sebastian Muether, Robert Hoerster, Manuel Marcel Hermann, Bernd Kirchhof, Sascha Fauser · 2012 · Graefe s Archive for Clinical and Experimental Ophthalmology
Handheld Shape Discrimination Hyperacuity Test on a Mobile Device for Remote Monitoring of Visual Function in Maculopathy
Yi‐Zhong Wang, Yu-Guang He, Gina Marie Mitzel, Song Zhang, Mike Bartlett · 2013 · Investigative Ophthalmology & Visual Science
Management of retinal vascular diseases: a patient-centric approach
Christopher Brand · 2012 · Eye
Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration
Fauser, Sascha, Schwabecker, Viktoria, Muether, Philipp S. · 2014 · American Journal of Ophthalmology
Minimizing the endophthalmitis rate following intravitreal injections using 0.25 % povidone–iodine irrigation and surgical mask
Hiroyuki Shimada, Takayuki Hattori, Ryusaburo Mori, Hiroyuki Nakashizuka, Kyoko Fujita, Mitsuko Yuzawa · 2013 · Graefe s Archive for Clinical and Experimental Ophthalmology
Comparison of Binding Characteristics and In Vitro Activities of Three Inhibitors of Vascular Endothelial Growth Factor A
Jihong Yang, Xiangdan Wang, Germaine Fuh, Lanlan Yu, Eric Wakshull, Mehraban Khosraviani, Eric S. Day, Barthélemy Demeule, Jun Liu, Steven J. Shire et al. · 2014 · Molecular Pharmaceutics
Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes
Jeeyun Ahn, Hyuncheol Kim, Se Joon Woo, Ji Hyun Park, Sun Young Park, Daniel Duck-Jin Hwang, Kyu Hyung Park · 2013 · Journal of Ocular Pharmacology and Therapeutics
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
Hiroki Tsujinaka, Jie Fu, Jikui Shen, Yun Yu, Zibran Hafiz, Joshua C. Kays, David A. McKenzie, Delia Cardona, David Culp, Ward M. Peterson et al. · 2020 · Nature Communications
Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
Stephanie Kaiser, Sruthi Arepalli, Justis P. Ehlers · 2021 · Journal of Experimental Pharmacology
What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?
Robert L. Avery · 2013 · British Journal of Ophthalmology
Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
Lotery, A, Griner, R, Ferreira, A, Milnes, F, Dugel, P · 2017 · Eye